| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
apolipoprotein E | 0.338 | 0.962 | 1.9E-03 |
|
disease | 0.400 | None | 0.867 | 15 | 0 | 1997 | 2018 | ||||||||
|
C-C motif chemokine ligand 2 | 0.321 | 0.962 | 0.61 |
|
disease | 0.380 | None | 1.000 | 8 | 0 | 2003 | 2019 | ||||||||
|
angiotensinogen | 0.367 | 0.923 | 5.0E-08 |
|
disease | 0.350 | None | 1.000 | 5 | 1 | 1998 | 2007 | ||||||||
|
glutathione S-transferase pi 1 | 0.383 | 0.923 | 1.4E-02 |
|
disease | 0.330 | None | 0.667 | 3 | 1 | 2004 | 2012 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
disease | 0.330 | None | 1.000 | 3 | 0 | 2007 | 2019 | ||||||||
|
heme oxygenase 1 | 0.381 | 0.923 | 9.7E-03 |
|
disease | 0.320 | None | 0.667 | 3 | 0 | 2007 | 2018 | ||||||||
|
plasminogen activator, urokinase | 0.425 | 0.923 | 2.3E-06 |
|
disease | 0.310 | None | 1.000 | 2 | 0 | 1999 | 2008 | ||||||||
|
CD163 molecule | 0.427 | 0.846 | 8.3E-04 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
podocalyxin like | 0.551 | 0.731 | 1.0E-03 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
Fas ligand | 0.430 | 0.885 | 0.18 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2004 | 2004 | ||||||||
|
muscle RAS oncogene homolog | 0.590 | 0.731 | 0.92 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
angiotensin I converting enzyme | 0.328 | 0.923 | 1.0E-37 |
|
disease | 0.100 | None | 0.909 | 11 | 0 | 1995 | 2018 | ||||||||
|
paraoxonase 1 | 0.409 | 0.885 | 9.8E-11 |
|
disease | 0.100 | None | 1.000 | 10 | 2 | 1998 | 2019 | ||||||||
|
CDKN2B antisense RNA 1 | 0.491 | 0.769 |
|
disease | 0.100 | None | 1.000 | 1 | 5 | 2018 | 2018 | |||||||||
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4 | 0.450 | 0.885 | 1.00 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
craniofacial development protein 1 | 0.619 | 0.615 | 3.7E-03 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
methylenetetrahydrofolate reductase | 0.337 | 0.885 | 3.2E-10 |
|
disease | 0.080 | None | 1.000 | 8 | 2 | 1999 | 2010 | ||||||||
|
nitric oxide synthase 3 | 0.378 | 0.885 | 6.7E-07 |
|
disease | 0.070 | None | 0.857 | 7 | 1 | 2001 | 2007 | ||||||||
|
toll like receptor 4 | 0.321 | 0.962 | 4.6E-09 |
|
disease | 0.060 | None | 1.000 | 6 | 2 | 2003 | 2007 | ||||||||
|
fatty acid binding protein 4 | 0.500 | 0.808 | 5.2E-05 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 2011 | 2018 | ||||||||
|
apolipoprotein B | 0.453 | 0.808 | 1.9E-16 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 1998 | 2018 | ||||||||
|
C-reactive protein | 0.299 | 0.962 | 3.7E-03 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 2009 | 2019 | ||||||||
|
cholesteryl ester transfer protein | 0.512 | 0.731 | 1.2E-23 |
|
disease | 0.040 | None | 1.000 | 4 | 1 | 2000 | 2012 | ||||||||
|
matrix metallopeptidase 9 | 0.305 | 0.923 | 1.9E-17 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2006 | 2014 | ||||||||
|
phospholipase A2 group VII | 0.537 | 0.769 | 5.3E-22 |
|
disease | 0.040 | None | 1.000 | 4 | 1 | 2004 | 2018 |